PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 4,845.00
+75.00 (1.57%)
At close: Oct 16, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 65.48 billion as of October 16, 2026. It is the 30,551st most valuable company in the world and the 1,607th biggest in South Korea. Its market cap has decreased by 19.66% in one year.
Market Cap
65.48B
Enterprise Value
53.43B
Revenue
14.18B
Global Rank
Country Rank
#1,607 South Korea
PE Ratio
62.76
ChartMarket Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 65.48B, a decrease of -61.77%. That is a compound annual growth rate of -8.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 65.48B | -13.35% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 69.78B |
| CTCBIO | 68.86B |
| IMGT Co.,Ltd. | 65.70B |
| SunBio,Inc. | 65.47B |
| ABION | 60.91B |
| ADBiotech | 59.29B |
| NovMetaPharma | 58.69B |
| Psomagen | 56.17B |